Blogs
MDR vs UKCA: what MedTech founders need to plan for
Dual-market access is a strategic decision, not an afterthought. How to plan EU MDR and UKCA timelines so they support — rather than slow — your commercial goals.
Dual-market access is a strategic decision, not an afterthought. How to plan EU MDR and UKCA timelines so they support — rather than slow — your commercial goals.
A step-by-step framework for structuring technical documentation that anticipates Notified Body questions and reduces review cycles under EU…
How early regulatory strategy and a Notified Body-ready technical file helped a MedTech scale-up clear MDR review without…